THNR vs. EQTY ETF Comparison

Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to Kovitz Core Equity ETF (EQTY)

THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description

The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$26.64

Average Daily Volume

3,146

Number of Holdings ^*

* may have additional holdings in another (foreign) market

EQTY

Kovitz Core Equity ETF

EQTY Description

The Kovitz Core Equity ETF seeks long-term capital appreciation. Through our fundamental, research-driven process, we strive to build diversified portfolios of equity investments through the purchase of competitively advantaged and financially strong companies at prices substantially less than our estimate of their intrinsic values.

Grade (RS Rating)

Last Trade

$23.18

Average Daily Volume

49,346

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	THNR	EQTY
30 Days	-5.52%	2.14%
60 Days	2.66%	8.05%
90 Days	2.87%	6.26%
12 Months		28.32%

0 Overlapping Holdings

	Symbol	Grade	Weight in THNR	Weight in EQTY	Overlap

THNR Overweight 6 Positions Relative to EQTY

Symbol	Grade	Weight
LLY	D	14.78%
NVO	F	12.82%
AZN	D	7.38%
AMGN	D	5.12%
TMO	C	4.91%
PFE	D	4.78%

THNR Underweight 10 Positions Relative to EQTY

Symbol	Grade	Weight
META	A	-4.61%
GOOG	C	-4.53%
BDX	B	-4.51%
AMZN	C	-4.31%
AXP	A	-4.3%
KEYS	C	-4.18%
J	D	-4.07%
PM	B	-4.05%
ICE	A	-3.72%
BRK.A	C	-3.63%

THNR: Top Represented Industries & Keywords

Industries: Drug Manufacturers - Major Biotechnology Diagnostics & Research